- 全部删除
- 您的购物车当前为空
DYRKs-IN-1 has antitumor activity. DYRKs-IN-1 is a potent DYRKs (Dual-specificity tyrosine-phosphorylation-regulated kinases) inhibitor with IC50s of 9 nM and 5 nM for DYRK1B and DYRK1A, respectively.
DYRKs-IN-1 has antitumor activity. DYRKs-IN-1 is a potent DYRKs (Dual-specificity tyrosine-phosphorylation-regulated kinases) inhibitor with IC50s of 9 nM and 5 nM for DYRK1B and DYRK1A, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 17,200 | 3-6月 | |
50 mg | ¥ 22,800 | 3-6月 | |
100 mg | ¥ 29,500 | 3-6月 |
DYRKs-IN-1 相关产品
产品描述 | DYRKs-IN-1 has antitumor activity. DYRKs-IN-1 is a potent DYRKs (Dual-specificity tyrosine-phosphorylation-regulated kinases) inhibitor with IC50s of 9 nM and 5 nM for DYRK1B and DYRK1A, respectively. |
靶点活性 | DYRK1B:9 nM , DYRK1A:5 nM |
体外活性 | Dyrks-in-1 enhanced the efficacy of human colon cancer cell line SW 620 with EC50 at 27 nM. |
分子量 | 588.06 |
分子式 | C30H30ClN7O4 |
CAS No. | 1387090-01-8 |
密度 | 1.53 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容